
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.090 | 20.380 | 19.290 |
Stocks | 98.910 | 99.040 | 0.130 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 9.315 | 16.202 |
Price to Book | 0.972 | 2.699 |
Price to Sales | 0.501 | 2.106 |
Price to Cash Flow | 5.035 | 10.291 |
Dividend Yield | 4.999 | 2.809 |
5 Years Earnings Growth | 7.905 | 12.061 |
Name | Net % | Category Average |
---|---|---|
Communication Services | 20.520 | 9.348 |
Financial Services | 15.770 | 20.358 |
Consumer Defensive | 14.340 | 8.232 |
Healthcare | 13.810 | 12.334 |
Consumer Cyclical | 12.050 | 12.320 |
Technology | 7.650 | 20.008 |
Basic Materials | 5.780 | 9.171 |
Industrials | 4.720 | 14.170 |
Energy | 3.850 | 8.298 |
Real Estate | 1.530 | 4.556 |
Number of long holdings: 205
Number of short holdings: 491
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Continental AG | DE0005439004 | 2.91 | 77.34 | -1.33% | |
Molson Coors Brewing B | US60871R2094 | 2.71 | 50.00 | +0.38% | |
BT Group | GB0030913577 | 2.70 | 194.65 | -0.43% | |
Henkel VZO | DE0006048432 | 2.67 | 67.50 | -1.63% | |
Panasonic | JP3866800000 | 2.67 | 1,448.0 | 0.00% | |
Verizon | US92343V1044 | 2.59 | 41.62 | -0.98% | |
GSK plc | GB00BN7SWP63 | 2.59 | 1,408.50 | -3.16% | |
Bristol-Myers Squibb | US1101221083 | 2.56 | 46.86 | -3.42% | |
Swatch Group | CH0012255151 | 2.47 | 136.55 | -0.87% | |
Standard Chartered | GB0004082847 | 2.45 | 1,282.00 | -0.39% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SchroderIntlSlctAsiaOpA1AccPLNHdg | 5.51B | 2.64 | 2.27 | 4.16 | ||
Schroder AsianTR A1 Acc PLN | 5B | 2.93 | 6.00 | 5.52 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review